Renalytix Plc (AIM:RENX)
9.00
0.00 (0.00%)
Mar 26, 2025, 11:59 AM GMT+1
Renalytix Revenue
Renalytix had revenue of $1.25M USD in the quarter ending December 31, 2024, with 76.45% growth. This brings the company's revenue in the last twelve months to $2.89M, up 20.08% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
$2.89M
Revenue Growth
+20.08%
P/S Ratio
5.05
Revenue / Employee
$28.37K
Employees
102
Market Cap
29.81M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Renalytix News
- 7 days ago - Half Year 2025 Renalytix PLC Online Investor Presentation Transcript - GuruFocus
- 8 days ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Renalytix AI GAAP EPS of -$0.05, revenue of $1.25M; reaffirms outlook - Seeking Alpha
- 6 weeks ago - UBS Group AG Acquires Significant Stake in Renalytix PLC - GuruFocus
- 4 months ago - Renalytix AI reports Q1 results - Seeking Alpha
- 4 months ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire
- 9 months ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 9 months ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire